Therapeutics on SPi NewsFollow our SPi News RSS Feed for therapeutics

Featured therapeutics News

[30 Oct 2019] Pear Therapeutics Announces Agreement with Ironwood Pharmaceuticals to Evaluate Prescription Digital Therapeutics for Patients with GI Indications

[22 Oct 2019] Harpoon Therapeutics Announces Presentation on HPN328 at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

[15 Oct 2019] CRISPR Therapeutics and KSQ Therapeutics Announce License Agreement to Advance Companies’ Respective Cell Therapy Programs in Oncology

[11 Oct 2019] NeuBase Therapeutics Announces Appointment of Cancer Biologist and RNA Therapeutics Specialist Steven Dowdy, Ph.D., to Scientific Advisory Board

[10 Oct 2019] Rheostat Therapeutics Announces Rebrand to Caraway Therapeutics and New Kendall Square Office

[27 Sep 2019] Sarepta Therapeutics, Inc. (SRPT), Aclaris Therapeutics, Inc. (ACRS) & Canada Goose Holdings Inc. (GOOS) - Class Action Update - Bronstein, Gewirtz & Grossman, LLC

[25 Sep 2019] SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Merger of Proteon Therapeutics, Inc. with ArTara Therapeutics, Inc. is Fair to PRTO Shareholders

[23 Sep 2019] Proteon Therapeutics and ArTara Therapeutics Agree to Combine

[20 Sep 2019] GTT Communications, Inc. (GTT), Sarepta Therapeutics, Inc. (SRPT) & Aclaris Therapeutics, Inc. (ACRS) - Class Action Alert - Bronstein, Gewirtz & Grossman, LLC

[27 Aug 2019] Kintai Therapeutics Announces Collaborations with Leading Academic Centers to Identify Novel Targets for Cancer Therapeutics

[18 Jul 2019] SILENCE THERAPEUTICS AND MALLINCKRODT ANNOUNCE COLLABORATION TO DEVELOP AND COMMERCIALIZE RNAi THERAPEUTICS FOR COMPLEMENT-MEDIATED DISEASES

[27 Jun 2019] Global Cancer Stem Cell Therapeutics Market to 2023 - Led by Cellerant Therapeutics, Celularity, Gamida Cell, Nohla Therapeutics, and Sumitomo Dainippon Pharma Co

[13 Jun 2019] BlackThorn Therapeutics Closes $76 Million Series B to Advance Targeted Therapeutics for Mental Health

[06 Mar 2019] Report: Developing Opportunities within Sarepta Therapeutics, Sally Beauty, Danaher, Ellie Mae, BioCryst Pharmaceuticals, and Akcea Therapeutics — Future Expectations, Projections Moving into 2019

[27 Feb 2019] Myonexus Therapeutics Announces Accelerated Acquisition by Sarepta Therapeutics

[15 Feb 2019] Consolidated Research: 2019 Summary Expectations for Tenaris S.A, Rapid7, Halozyme Therapeutics, Cara Therapeutics, EnPro Industries, and K12 — Fundamental Analysis, Key Performance Indications

[03 Jan 2019] Aptevo Therapeutics Collects $3.3 Million In Escrow Funds From Saol Therapeutics

[27 Dec 2018] Factors of Influence in 2019, Key Indicators and Opportunity within Halozyme Therapeutics, Capricor Therapeutics, Appian, Yext, Agile Therapeutics, and Corbus Pharmaceuticals — New Research Emphasizes Economic Growth

[04 Dec 2018] Carnot BioSciences, a Spin off of SmartZyme BioPharma, and Hemoshear Therapeutics Partner to Develop Protein-Based Therapeutics for Rare Metabolic Diseases

[28 Nov 2018] New Research: Key Drivers of Growth for Mersana Therapeutics, Maiden, Payment Data, CareDx, Natera, and Spero Therapeutics — Factors of Influence, Major Initiatives and Sustained Production

[21 Nov 2018] Market Trends Toward New Normal in Transcat, BioXcel Therapeutics, Youngevity International, Aquestive Therapeutics, TORM, and Transglobe Energy — Emerging Consolidated Expectations, Analyst Ratings

[05 Nov 2018] Cybrexa Therapeutics to Present Preclinical Data for its Tumor-Selective Technology Platform at the 30th EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium

[17 Oct 2018] Market Trends Toward New Normal in Halozyme Therapeutics, Fitbit, Iconix Brand Group, Leap Therapeutics, LightPath Technologies, and Capricor Therapeutics — Emerging Consolidated Expectations, Analyst Ratings

[25 Jul 2018] Rubius Therapeutics to Acquire Manufacturing Facility in Smithfield, Rhode Island to Produce Red Cell Therapeutics

[24 Jul 2018] Nabriva Therapeutics Strengthens Antibiotics Leadership Position with Acquisition of Zavante Therapeutics

[23 Jul 2018] Arcturus Therapeutics Achieves Program Milestones and Refines Agreement with Cystic Fibrosis Foundation Therapeutics

[04 Jun 2018] BioXcel Therapeutics and Nektar Therapeutics Present Preclinical Pancreatic Cancer Data for BXCL701, NKTR-214 and Anti-PD1 Combination Therapy at ASCO 2018 Annual Meeting

[29 May 2018] New Research Coverage Highlights Cision Ltd., FCB Financial, Akcea Therapeutics, RE/MAX, Pain Therapeutics, and Regal Beloit — Consolidated Revenues, Company Growth, and Expectations for 2018

[24 Apr 2018] Third Rock Ventures Launches Cedilla Therapeutics with $56 Million Investment to Target Protein Stability Using Small Molecule Therapeutics

[18 Apr 2018] Sandoz signs agreement with Pear Therapeutics to develop and commercialize prescription digital therapeutics for patients with substance use disorder and opioid use disorders

[18 Apr 2018] Pear Therapeutics and Sandoz Announce Deal to Commercialize Prescription Digital Therapeutics

[01 Mar 2018] Novartis and Pear Therapeutics to develop digital therapeutics for patients with schizophrenia and multiple sclerosis

[17 Jan 2018] Arcturus Therapeutics Announces Expansion of Collaboration with Takeda Pharmaceuticals to Develop RNA-based Therapeutics for the Treatment of Nonalcoholic Steatohepatitis (NASH) and Other GI Disorders

[19 Sep 2017] Acer Therapeutics and Opexa Therapeutics Close Merger and Financing

[17 May 2017] Cara Therapeutics to Present at the 17th Annual Conference on Pain Therapeutics

[25 Apr 2017] Click Therapeutics Announces Multiple Publications of Clinical Data Supporting Digital Therapeutics™ Programs for Smoking Cessation and Major Depressive Disorder

[17 Apr 2017] CRISPR Therapeutics and Casebia Therapeutics Announce Exclusive Development and Option Agreement with StrideBio

[05 Apr 2017] Finch Therapeutics and Takeda Announce Global Collaboration to Develop Microbiome Therapeutics in Inflammatory Bowel Disease (IBD)

[14 Mar 2017] CRISPR Therapeutics and Casebia Therapeutics Announce Commercial License Agreement With MaxCyte

[04 Nov 2016] Aimmune Therapeutics Announces $145 Million Equity Investment by Nestlé Health Science, Demonstrating Shared Commitment to Advancing Food Allergy Therapeutics

[23 Sep 2016] Delisting of Securities of BIND Therapeutics, Inc., InterCloud Systems, Inc., Echo Therapeutics, Inc., 1347 Capital Corp., and EPIRUS Biopharmaceuticals, Inc. from The Nasdaq Stock Market

[06 Jan 2016] Rosetta Genomics Grants Sublicenses to Mirna Therapeutics for microRNA-related Patents for the Development of Oncology Therapeutics

[04 Aug 2015] MorphoSys and G7 Therapeutics Sign Alliance to Develop Innovative Antibody Therapeutics

[04 Aug 2015] MorphoSys and G7 Therapeutics Sign Alliance to Develop Innovative Antibody Therapeutics

[29 Jul 2015] Biotechnology Stocks Review -- Juno Therapeutics, Amicus Therapeutics, ImmunoGen, CEL-SCI, and Ignyta

[29 Jul 2015] Bellerophon Therapeutics Expands License Agreement With INO Therapeutics to Develop INOpulse(R) for Three Additional Cardiopulmonary Diseases

[15 Jul 2015] Active Equities to Watch in the Biotechnology Industry -- Prima Biomed, Oncothyreon, Opko Health, ImmunoCellular Therapeutics, and Adaptimmune Therapeutics

[12 Jan 2015] Fate Therapeutics Announces Key 2015 Objectives for the Advancement of Programmed Cellular Therapeutics Pipeline

[05 Dec 2014] Stemline Therapeutics Announces Multiple Preclinical Presentations Highlighting Its Pipeline of IL-3R-Directed Therapeutics at the American Society of Hematology (ASH) Annual Meeting

[10 Jul 2014] Pre-market Equity Watch on Biotech Industry -- Research on Halozyme Therapeutics, XOMA, Amicus Therapeutics, and Arena Pharma


Still looking?

Type in your search term below and click Enter

World News from SPi

Sector Publishing Intelligence [SPi'] publishes financial news from around the world FAST. For breaking news announcements from companies, blogs and commentators, SPi provides up to the minute, integrated news on all aspects of financial markets and financial services.

SPi's extensive database of corporate information shows company details alongside breaking corporate news from the world’s largest news providers.

Publish Your Stories with SPI

Please click here to find out how to submit press releases and articles for publication.

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us